监管变更后门诊全髋关节置换术量增长近8倍,人群扩大而结局不变:10年分析
基于美国国家手术质量改进计划数据库2010年1月至2021年12月的332,423例初次全髋关节置换术,2019至2021年住院全髋关节置换术量下降55%,门诊全髋关节置换术量增加751%。2019年后接受全髋关节置换术的患者更年长、女性更多、白人更多、美国麻醉医师学会III级更多,门诊队列30天并发症、再入院和再手术更少。作者认为在适当患者选择和优化下支持向门诊全髋关节置换术的安全过渡。
要点
- 2019至2021年住院全髋关节置换术量下降55%(42,779至19,075),门诊全髋关节置换术量增加751%(2,518至21,424)。
- 2019年后接受全髋关节置换术的患者更年长、女性更多、白人更多、美国麻醉医师学会III级更多(均P < .001)。
- 门诊队列30天并发症、再入院和再手术更少,作者认为在适当患者选择和优化下支持安全过渡。
核心结论
- 2020年从住院-only清单移除后,门诊全髋关节置换术量增加近8倍。
- 尽管 eligibility 扩大至更年长和更多合并症患者,30天并发症、再入院和再手术仍低。
- 作者认为这些发现支持在适当患者选择和优化下向门诊全髋关节置换术的安全过渡。
研究设计与样本
- 回顾性查询美国国家手术质量改进计划数据库2010年1月至2021年12月的初次全髋关节置换术。
- 共纳入332,423例全髋关节置换术,其中住院292,974例(88%),门诊39,449例(12%)。
- 主要结局为门诊和住院全髋关节置换术的年手术量;次要结局为30天并发症、再入院和再手术。
- 组间变量采用拟合优度卡方检验和汇总统计进行分析。
主要发现
- 2019至2021年住院全髋关节置换术量下降55%(42,779至19,075),门诊全髋关节置换术量增加751%(2,518至21,424)。
- 2019年后接受全髋关节置换术的患者更年长(P < .001)、女性更多(P < .001)、白人更多(P < .001)、美国麻醉医师学会III级更多(P < .001)。
- 门诊队列的30天并发症、再入院和再手术更少。
- 两队列住院时间均下降至2019年,2020和2021年住院全髋关节置换术的住院时间增加,而两队列的家庭出院和手术时间增加。
临床怎么用
- 作者认为这些发现支持在适当患者选择和优化下向门诊全髋关节置换术的安全过渡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the removal of total hip arthroplasty (THA) from the inpatient-only (IPO) lists, the orthopedic landscape across the United States has changed rapidly. Thus, this study aimed to: 1) characterize the change in THA volume for outpatient and inpatient surgeries; 2) elucidate demographical differences before and after removal from the IPO list; and 3) analyze 30-day complications, readmissions, and reoperations. METHODS: The National Surgical Quality Improvement Program database was queried for primary THAs between January 2010 and December 2021. The primary outcome was the annual volume of outpatient and inpatient THAs. Secondary outcomes involved 30-day complications, readmissions, and reoperations. The variables between cohorts were analyzed using goodness-of-fit Chi-square tests with summary statistics. RESULTS: Of the 332,423 THAs between 2010 and 2021, 88% were inpatient THAs (n = 292,974) and 12% were outpatient THAs (n = 39,449). From 2019 to 2021, the volume of inpatient THA decreased by 55% (42,779 to 19,075), while outpatient THA increased by 751% (2,518 to 21,424). Patients who had a THA after 2019 were older (P < .001), more commonly women (P < .001), white (P < .001), and more likely American Society of Anesthesiologists Class III (P < .001). The outpatient cohort had fewer 30-day complications, readmissions, and reoperations. The length of stay for both cohorts decreased until 2019, before increasing in 2020 and 2021 for inpatient THAs, while home discharge and operative time increased for both. CONCLUSIONS: The volume of outpatient THA increased almost eightfold after its removal from the IPO lists in 2020. Despite expanding eligibility with older patients and more comorbidities, 30-day complications, readmissions, and reoperations remain low. These findings support the safe transition to outpatient THA with appropriate patient selection and optimization.
引用
- Pasqualini I, Turan O, Emara AK, et al. Outpatient Total Hip Arthroplasty Volume up Nearly 8-Fold After Regulatory Changes With Expanding Demographics and Unchanging Outcomes: A 10-Year Analysis. J Arthroplasty. 2024. PMID: 38401607. doi:10.1016/j.arth.2024.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。